CervoMed (CRVO) Misses Q3 EPS by 55c

CervoMed (NASDAQ: CRVO) reported Q3 EPS of ($0.55). Revenue for the quarter came in at $1.94 million.

For earnings history and earnings-related data on CervoMed (CRVO) click here.

You May Also Be Interested In

• Bessent on Iran: maximum economic pressure means likely not a kinetic restart
• ScanSource (SCSC) Tops Q4 EPS by 32c
• UBS Reiterates Buy Rating on Dutch Bros Inc. (BROS): 'One of Strongest Growth Stories in Restaurants'